Filing Details

Accession Number:
0001358403-19-000114
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-30 16:01:17
Reporting Period:
2019-08-29
Accepted Time:
2019-08-30 16:01:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358403 Bellicum Pharmaceuticals Inc BLCM Pharmaceutical Preparations (2834) 201450200
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638380 Shane Ward C/O Bellicum Pharmaceuticals, Inc.
2130 W. Holcombe Blvd., Ste. 800
Houston TX 77030
Sr. Vp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-29 8,000 $1.23 18,294 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 1,359 shares acquired by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan on June 10, 2019.